The pace of innovation in the biotech industry operated at speed during the pandemic, showing that innovations in the sector aren't decades into the future, they're.
The US-dominated biotech landscape is evolving as aging populations and lifestyle-related diseases become global health issues, impacting Asia, as much as the rest.